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1. Introduction 
The oxidizing environment, shared by all aerobic organisms and crucial for their survival, 
poses a continuous threat to cellular structures all the living beings are made of. Structural 
proteins and lipids, and cellular membranes they compose, nucleic acids and enzymes that 
govern vital cellular processes are all susceptible to oxidative damage. Dealing with this 
inevitable and constant danger is one of the greatest challenges the living being with aerobic 
metabolism has to meet.  
2. The implication of cellular redox balance in cell proliferation 
2.1 Reactive oxidative species in cell proliferation 
Classical work of Kelvin Davies (Davies, 1999), more than ten years ago, showed that the 
cells show a whole range of responses to oxidative stress that depends on the intensity of the 
stress. Low level of hydrogen peroxide induced mitogenic responses and stimulation of 
proliferation; this observation was firstly reported by Oberly (Oberly et al., 1981) who have 
described that oxidative stimuli, such as superoxide and hydrogen peroxide, could activate 
signalling pathways that lead to proliferation. Davies et al. further assert that considerable 
increase in the oxidant concentrations caused temporary growth arrest which became 
permanent with a progressive increase. When high H2O2 concentrations were used, 
apoptosis took place and at very high oxidant levels the cells were killed by necrosis. A year 
later, (Pani et al., 2000) demonstrate a causal link between redox changes and growth control 
by cell density: they show that low level of oxygen species in the environment of 
proliferating cells was not only stimulating but necessary for the correct mitogenic 
signaling. This study was immediately followed by the work of Menon et al., 2003 who 
suggested that an oxidation event early in G1 phase may be a critical regulatory step in the 
progression of the cells into S phase. This lead to the development of the model of the 
“redox cycle within a cell cycle” proposed by the same group several years later (Menon & 
Goswami 2007). 
According to this model, the transient change in ROS could modify the redox state of cell 
cycle regulatory proteins, at their critical cysteine residues, and thus determine progression 
or arrest in the proliferation. Antioxidant mechanism could scavenge ROS and reverse the 
process. In accordance to these reports, Barry Halliwell (Halliwell, 2007) draw a complete 
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view of the present knowledge of the role of oxidative stress in promoting cancer, its 
damaging effects to DNA, and its action on cell proliferation and apoptosis. Malignant cells 
produce more radical species and, although antioxidant defence could also be induced in 
these cells, they display a pro-oxidant state. However, apparently the oxidative stress 
generated in these high proliferative cells does not exceed the level where oxidative damage 
becomes so severe that cell function is impaired. This finding is in line with previously cited 
reports and many others that support the role of reactive oxidative species mediated 
signalling in the promotion of cell growth. 
2.2 The bridge between the oxidative stress and cell proliferation - Glutathione 
Glutathione (GSH) is the most abundant non-protein thiol in mammalian cells (Meister & 
Anderson, 1983). It is considered essential for survival in mammalian cells (Viña, 1990) and 
yeast Meister & Anderson, 1983; Viña et al., 1978), but not in prokaryotic cells. The exact 
nature of this important difference has not been elucidated. Glutathione was discovered in 
1888 by Rey Pailhade as “organic hydrogenate of sulphur” (Rey Paihade, 1988) and 
“rediscovered” and fully described by Sir Frederic Gowland Hopkins in the 1920s (Hopkins, 
1929) and quoted by Sies several years later (Sies, 1999). 
Glutathione has attracted the scientific interest with variable intensity along the century 
since its discovery and many important cellular functions of this tripeptide were revealed 
along the years. Glutathione shows a widespread localization within cells and considerably 
high concentration in cells and tissues (up to 10 mM) (Tateishi et al., 1974). Examples of 
normal physiological functions of glutathione known for a long time include regulation of 
the transport of certain amino acids (Viña & Viña, 1983) control of cytoskeleton assembly 
(Burchil et al. 1978) and regulation of enzymatic activity (Ernst et al., 1978; Ziegler, 1985). 
During 1960s, GSH was demonstrated to be a co-substrate for a number of important 
enzymatic reactions: GSH-S-transferase was described (Booth, 1961) and its role in a first–
line defence against electrophilic insult, obviously dependent on glutathione, was suggested 
(Boyland, 1969). These pioneer works became the bases for many studies that lead to the 
development of concepts such as drug and foreign compound detoxification, and multidrug 
resistance (Smith, 1977) of crucial importance in the modern cancer therapy. Glutathione, as 
it lacks toxicity linked to cysteine (Viña et al., 1983), is considered perfect as a cellular thiol 
“redox buffer” with a purpose to maintain a given thiol/disulfide redox potential (Sies, 
1999). Therefore, the redox properties and abundance that characterize this molecule grant it 
a major role in protecting the cell against oxidants and electrophiles, and during 1980s this 
particular role of glutathione is central in many research efforts.  
Association of redox regulation with toxicity events lead to the introduction of the concept 
of “oxidative stress” at biochemical and cellular level (Sies & Cadenas, 1985). Oxidative 
stress is generally defined as an imbalance between prooxidants and antioxidants with a 
considerable effect on other cellular components, including redox sensitive functional 
groups of proteins. Nowadays, with the increasing awareness of the importance of ROS and 
glutathione in cellular signalling, and the cellular redox environment in fundamental 
physiological processes, a new definition of oxidative stress is proposed. According to Jones, 
2006, oxidative stress may be better defined as a disruption of redox signaling and control. 
Interestingly, more than 10 years ago, searching for a molecular link between oxidative 
stress and cell proliferation, Cotgrave IA and Gerdes RG recommended similar term: 
“oxidant mediated regulation” (Cortgreave and Gerdes, 1998). 
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2.3 Glutathione in cell proliferation 
Several studies from more than 20 years ago have suggested that changes in low molecular 
weight thiols (LMWT) are associated with regulation of cell growth. Harris and Patt 
published (Harris & Pat, 1969) that nonproliferating mouse tumour cells contained LMWT 
than proliferating cells and in early eighties various authors report similar results: human 
lung and ovarian tumour cells during the exponential growth demonstrate higher GSH 
levels than during nondividing state (Harris & Pat, 1969; Post, 1983). In accordance to these 
findings, Kosower and Kosower (Kosower & Kosower, 1978) have demonstrated that 
decrease of GSH biosynthesis in vivo inhibits tumour growth rate. Moreover, it was 
suggested that cellular GSH may have to reach certain critical levels before proliferation can 
be initiated and that variations in the protein sulphydryl redox status may directly relate to 
regulation of cell growth (Atzori et al. 1990).  
Defining the intrinsic cellular redox environment by estimation of glutathione 
(GSH)/glutathione disulfide (GSSG) redox state, the group of Dean P. Jones (Nkabyo et al. 
2002) concluded that each phase in the life of the cell is characterized by the certain redox 
state. Proliferating cells are in the most reduced state, with the values of Eh between -260mV 
and -230mV (Schafer & Buettner, 2001). Upon a growth arrest caused by differentiation 
(Nkabyo et al. 2002) or contact inhibition (Schafer & Buettner, 2001) cells are 40 mV more 
oxidised (-220mV to -190mV) while the apoptotic process is accompanied by further 
oxidation up to -165mV (Sun & Oberley, 1996). 
Therefore, while the cell progresses from proliferation, through contact inhibition, 
differentiation, and finally apoptosis, there is an intrinsic and natural progression from more 
reduced to more oxidised cellular redox environment. The universality of this model which 
applies to various cells from different organisms (reviewed in Schafer & Buettner, 2001) 
inspired a daring hypothesis of Schafer and Buettner on the implication and function of 
thiols and disulfides as nano-switches. The GSSG/2GSH couple is imagined as a 
switchboard that move the cell from proliferation through differentiation towards 
programmed cell death, if the redox environment could not be maintained, or necrosis when 
the oxidative insult is to severe. 
2.4 Glutathiolation of regulatory proteins as a link between a stimulating oxidative 
event and reduced cell environment in cell proliferation  
During the last two decades the increasing body of evidence reveals that several 
transcription factors undergo oxidant modification necessary for their activation. For 
instance, the property of binding DNA and thus regulate gene expression of AP1, NfkB, p53, 
and SP1 depends on the redox status of cysteinyl thiols in their structures (Sun & Oberley, 
1996). Thus, the idea of protein glutathiolation as a regulatory mechanism of importance in 
cell proliferation came into sight.  
Glutathiolation is a protein modification which consists in the covalent union of the 
tripeptide glutathione to the SH group of the cysteine residue. For a long time this reaction 
was considered to be a consequence of the equilibrium between protein thiols and GSSG 
inevitably related to oxidative stress. From this point of view, glutathiolation fulfills two 
important functions. Firstly, its reversibility enables the preservation of glutathione in the 
cell and serves as a buffer for the reduction potential; otherwise, GSSG efflux would cause 
the loss of GSH from the cell, decreasing the reducing capacity which could be recovered 
only by the synthesis of new GSH (Schafer & Buettner, 2001). Secondly, it provides 
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protection for protein-SH against irreversible modifications and protein damage in response 
to higher levels of oxidative stress (Dalle-Donne et al., 2007). Interestingly, it was 
demonstrated that glutathiolation as a posttranslational modification occurs not only during 
oxidative stress, but also under basal conditions and is involved in regulating distinct 
transcription factors, such as NF-kB (Pineda-Molina et al., 2001), its inhibitor factor IKK 
(Reynaert et al., 2006) and c-Jun (Canela et al. 2007). Apparently, the binding capacity of 
these proteins to DNA or other proteins is modulated by glutathiolation. This relatively 
recent focus on the implication of glutathiolation modulatory effects on protein function 
yielded important breakthrough in elucidation of the implication of this modification in 
various physiological and pathological situations (Giustarini et al. 2004) and raises 
interesting questions about its possible implications in cell proliferation.  
2.4.1 The role of glutathione in DNA synthesis 
Among the important roles that GSH plays in cellular physiology, and among the first to be 
described, was its role in DNA synthesis. The pentose phosphate pathway is a cellular 
source of NADPH that is involved in reductive biosynthesis. In this process, ribose-5-
phosphate is formed and subsequently used for the synthesis of RNA, DNA and nucleotide 
coenzymes. Apart from the synthesis of nucleotides, NADPH is also required for the 
formation of amino acids, fatty acids, cholesterol, neurotransmitters and nitric oxide (NO). 
Furthermore, NADPH is the source of electrons in the process of reduction of 
ribonucleotides to deoxyribonucleotides catalyzed by the ribonucleotide reductase 
(Thelander & Reichard, 1979). 
The route is initialized by two distinct but complemented systems, the thioredoxin system 
and the glutaredoxin system. Thioredoxin operates by transferring the electrons to 
ribonucleotide reductase, and they are supplied by the thioredoxin reductase and NADPH. 
The glutaredoxin system is initialized by the glutathione reductase, which reduces the GSSG 
to GSH using the NADPH as source of electrons. GSH is used by the glutaredoxin to 
provide the reducing power to the ribonucleotide reductase (Zahedi et al., 2009). 
The crucial role of glutathione in DNA synthesis has been extensively documented 
(Thelander & Reichard, 1979; Holmgren, 1976). For instance, Dethlefsen and co-workers 
(Dethlefsen et al. 1988) showed that glutathione depletion inhibits DNA synthesis in 
mammary carcinoma cells. In addition, the vital importance of GSH in this process has also 
been demonstrated in human T lymphocytes (Suthanthiran et al., 1990). As mentioned 
above GSH is an indispensable requirement in eukaryotes. In contrast, it does not 
demonstrate the same importance in prokariotes. It has been shown that E. Coli lacking 
gshA, the rate limiting enzyme in the synthesis of GSH, can grow without GSH 
supplementation (Greenberg & Demple, 1986; Miranda-Vizuete et al., 1996). On the 
contrary, in yeast, the depletion of GSH does affect cell proliferation on the level different 
from DNA synthesis: mutants deficient in GCS after GSH withdrawal arrest cells in G1, 
whereas a strain with a defect in ribonucleotide reduction arrest cells in S phase (Wang et 
al., 1997). Since other possible explanations, such as protection against oxidative stress or 
protection against non-native protein disulfides, have been discarded (Spector el al., 2001), it 
appears that the essential function of GSH in yeast is related to the redox properties of its 
thiol group. Consequently, glutathione can be replaced by dithiothreitol, but not with a GSH 
analog where a thiol group has been substituted by a methyl group (Grant et al., 1996). Since 
GSH is the reductant for glutaredoxin as explained previously, and glutaredoxin is also 
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essential (Rodriguez-Manzaneque et al., 1999) presumably their vital importance may be 
interdependent. Then GSH seems to be important in S phase. During the process of DNA 
replication, errors, such as double-strand breaks (DSBs) that arise from stalled replication 
forks, require attention by the DNA damage response proteins. Thus, the correct control of 
DNA synthesis and probably essential molecules, such as GSH, are necessary for the correct 
DNA processing.  
One of the most important proteins involved in DNA damage signaling pathway is the 
ataxia-telangiectasa mutated protein (ATM). This central signaling protein, mainly for DSBs, 
is involved in the repairing DNA process necessary after replication stress. Thus cells 
lacking ATM fail to execute many of the cellular responses to DNA damage (Zhou & 
Elledge, 2000). In addition, control of ATM responses after DNA replication may be 
necessary for the correct cell cycle control. In that way, ATM is a central component in the 
cell cycle regulation. Therefore, patients with ataxia telangiectasia have reduction in DNA 
synthesis (Painter & Young, 1980). Furthermore, a recent work published by Guo Z. and 
coworkers describes using a series of elegant experiments how ATM sense the redox 
changes to modulate their activity (Guo et al, 2010). Interestingly, these authors propose that 
ATM may regulate global cellular responses to oxidative stress, remarking the essential link 
between redox control and DNA interacting, remodeling or repairing proteins. In Fanconi 
anemia for instance, Castillo and coworkers have shown that ATM dependent 
phosphorylation of FANCD2, one of the main proteins in the Fanconi anemia pathway of 
DNA repair, is necessary for normal S-phase checkpoint activation after oxidative stress 
(Castillo et al, 2011). 
2.4.2 Regulation of telomerase activity by glutathione 
The eukaryotic chromosomes are capped by telomeres, which consist of TTAGGG DNA 
sequences repeated in tandem, associated with several proteins, which protect the final 
regions of chromosomes. These structures play an important role in the stability and the 
complete replication of the chromosomes. Conventional DNA polymerases cannot fully 
replicate the 3’-end of the lagging strand of linear molecules, and therefore in every cell 
division telomeric sequences are lost (Komberg, 1969). Telomerase is an important enzyme 
that ensures the maintenance of normal telomere length. This activity is high in human 
cancers (Kim et al., 1994), but virtually absent in normal human tissues, except germinal 
cells (Harley et al., 1990). Telomerase regulation is not completely understood, but its 
changes are related to both cancer and aging (Sharpless & Depinho, 2004). Studies carried 
out by Jady et al. show that human telomeres are more accessible during the S-phase (Jady 
et al., 2006) and that the telomerase assembly with telomeres takes place at this specific 
moment of the cell cycle (Jady et al., 2006; Tomlison et al., 2006). Telomerase plays a key role 
in cellular homeostasis, because it maintains the length of the telomeres. This especially 
important in germinal cells in which it is necessary to keep a normal telomeric length after 
many cellular divisions. Important contributions about the epigenetic control of telomeres 
have been reported recently (Koziel et al., 2011). In that way, Maria Blasco has suggested 
that telomeres are under epigenetic control (García-Cao et al., 2004). Mammalian telomeres 
and subtelomeric regions are enriched in epigenetic marks that are characteristic of 
heterochromatin. In addition, histone deacetylase enzymes, such as Sirt6, regulate the 
telomeric chromatin conformation in order to allow the interaction of WRN protein with 
these chromosomal regions (Michishita et al., 2008). 
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There are evidence that point to a role of redox environment in a short term regulation of 
the activity of this important enzyme. Minamino et al., 2001, using vascular smooth muscle 
cells, reported that hypoxia up-regulates telomerase activity. Hypoxia is known to lower 
oxidative stress and thus to increase levels of glutathione. A specific inhibitor of telomerase, 
2-[3-(trifluoromethyl) phenyl]isothiazolin-3-one, reacts with a key cysteine residue, which is 
essential for telomerase activity and must be kept reduced. Consequently, it has been 
reported that dithiothreitol reverses this inhibition (Hayakawa et al., 1999). Furthermore, 
antioxidants have been shown to inhibit nuclear export of telomerase reverse transcriptase 
and thus delay replicative senescence of endothelial cells (Haendeler et al., 2004). In 
conclusion, a critical cysteine residue must be kept reduced in order to maintain full 
telomerase activity. It is likely that the glutathione redox potential may be important in this 
process. 
Previous findings of our group showed that telomerase is regulated by the shift in 
glutathione redox potential within values similar to those found in vivo and alterations in 
telomerase activity are coordinated with changes in critical cell cycle proteins, particularly 
Id2 and E2F4 (Borras et al., 2004).  
 
 
Fig. 1. Reduced glutathione regulates telomerase activity in 3T3 fibroblasts. 
Thus, physiological variations in glutathione level induce changes in telomerase activities 
that are in concordance with changes in cell cycle regulatory proteins. A number of reports 
have shown similar results. Brown et al., 2007 demonstrated for the first time in vivo that 
high hepatic glutathione levels correlate with increased telomerase activity. Also, the 
importance of glutathione regulation in telomerase activity has been proved in endothelial 
progenitor cells (EPC): impairment of antioxidant defences in EPC promoted oxidant 
mediated apoptosis and telomerase inactivation which subsequently lead to development 
and/or progression of atherothrombosis (Fujii et al., 2006). 
Recent data suggest that telomerase activity is regulated and ordered by telomere structure 
and telomerase assembly. Experimental evidence suggests that the telomere structure may 
change in a cell cycle-dependent manner to restrict telomerase activity to S phase (Hug & 
Ligner, 2006). In addition, telomere structure and specially the telomeric G-overhangs 
generation are strictly regulated during S phase and prolonged to other cell cycle phases 
depending on whether are telomeres from the lagging or the leading telomere (Dai et al., 
2010). For this to happen, the precise control of the changes not only in telomerase 
conformation, but in chromatin structure (i.e. in its compactation level) as well, is of vital 
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importance. This finding that telomere length, and, therefore, telomere structure, is tightly 
regulated in telomerase proficient cells invokes a connection between cell cycle, telomerase 
and telomere structure (Blasco, 2002). In other words, the mechanism that lies beneath 
telomerase regulation might be related with the mechanism that control cell proliferation. 
This opens a highly significant area for exploratory study and the diversity of processes and 
control mechanisms that could be involved in this phenomenon remain to be elucidated. 
3. Compartmentalization of glutathione 
3.1 The physiological importance of compartmentalization of glutathione 
Pioneer work from Meister, (Meister & Anderson, 1983) correlated GSH synthesis and its 
degradation throughout the so-called -glutamyl cycle, and defined it as a cytosolic 
processes. The importance of cellular compartmentalization of GSH is two fold, first because 
it plays an important role in fighting against radical oxygen species (ROS). It is well known 
that these molecules have a very short half life and exert their action close to the place they 
were produced. Thus, the presence or absence of GSH could determine the development of 
localized oxidative damage for the cell structure or metabolic function developed in the 
vicinity. Secondly, GSH compartmentalization is of vital importance because of its role as a 
cellular detoxifying agent; it is known that tumours that have high glutathione levels are 
more resistant to chemotherapy, and the importance of nuclear (Voheringer et al., 1998) and 
mitochondrial (Benlloch et al. 2005) compartmentalization of GSH has been pointed out. 
The overview of compartmentalization of glutathione in mammal cells is a complicated 
matter. This is due to the presence in the literature of a number of contradictory reports. The 
reason for the controversy is mainly methodological. Until very recently most reports were 
mainly based on cell-fractionation techniques. Those techniques appear to be reliable for 
mitochondrial studies; however their usefulness in nuclear or even endoplasmic reticulum 
measurements is at least controversial. 
3.1.1 Nucleus 
Although the role of nuclear GSH in the synthesis of DNA (Thelander & Reichard, 1979) and 
in protection against oxidative damage or ionizing radiation (Biaglow et al., 1983) is well 
established, little is known about the concentration of GSH in the nucleus and its regulation. 
This is due to two main factors. The first is methodological: it is impossible to determine the 
nuclear concentration of GSH using standard cell fractionation and analytical approaches 
(for a review see Söderdahl et al., 2003). The second factor is that most, if not all, of the 
reports share the common view of nuclear GSH distribution in a static situation. Cells are 
usually studied under steady state conditions i.e. when they are confluent (G0/G1 phase of 
the cell cycle). The nuclear membrane dissolves during mitosis and is formed again around 
newly replicated DNA packed in chromosomes; this spectacular change involves a variety 
of regulatory mechanisms. Therefore, if the nuclear GSH distribution is studied, the cell 
cycle physiology should be carefully considered.  
The role of GSH in cell cycle regulation has been addressed mainly from the point of view of 
its overall cellular content. This is surprising since it is in the nucleus where most cell cycle 
progression events take place. The nucleus changes dramatically during the different phases 
of cell cycle, and failing to consider the corresponding changes in its redox environment 
could confer an important disadvantage in elucidating the actual importance of glutathione 
in the control of cell proliferation.  
www.intechopen.com
 




Fig. 2. Modifications of nuclear proteins along the cell cycle. 
Our results, in general, are in accordance with the work of Hutter at al, (Hutter et al., 1997), 
who have studied the redox potential (E) in the normal and malignant cells along the cell 
cycle. The E of normal cells fluctuates during the cell cycle; for the proliferation to start it has 
to decrease at least 30mV comparing to its level in the G0 phase (where the cells are 100% 
confluent). On the contrary, in cancer cells, the E remains low throughout the complete cell 
cycle, even at a high cell density (Hutter et al., 1997). Our evaluation of the GSH levels along 
the cell cycle in different models indirectly confirms these findings.  
The work of Hutter et al. was further developed and completed by Hoffman et al. (Hoffman 
et al., 2008), who proposed recently a novel redox model of cell proliferation. They postulate 
the existence of a redox switch that helps regulate the proliferation within normal cells; its 
absence in cancer cells enables the bypass of the restriction point and leads to the loss of the 
control of cell cycle. The authors offer this model as a base to understand the aberrant 
cellular proliferation that leads to malignant transformation. 
According to “redox model of cell proliferation”, in normal cells exist a threshold value (θ) 
of E≤ 207±11mV which initiates the phosphorylation of different regulatory proteins 
associated with different phases of the cell cycle and, consequently, cell proliferation. When 
E>θ cell enters G1/G0 phase. However, when cancer cells are concerned, Hoffman does not 
take into account the fluctuations in the E level. In our hands, the increase in GSH level 
along the cell cycle (before the onset of the proliferation comparing to the GSH level at the 
final time point) is, indeed, less striking than in 3T3 fibroblasts; two-fold comparing to four-
fold, respectively. The author hypothesizes, though, the existence of a reductive limit of -
260mV which normal cell could not survive, but would not jeopardise cancer cell.  
It was proposed previously that the proliferation occurs within the range of ROS levels, 
concentrations above or below this range could lead to growth arrest or cell death; hence 
ROS could act like a dual-edged sword (Davies, 1999).  
3.2 Glutathione controls the cell cycle regulatory proteins 
3.2.1 Id2 as a redox sensitive protein 
The study of the expression of the Id2 along the cell cycle gave further support to this 
premise. The family of helix-loop-helix proteins denominated Id (inhibitor of DNA binding 
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or inhibitor of differentiation) was demonstrated to be of considerable importance in the 
regulation of cell growth, differentiation and cancer in many mammalian tissues (Norton, 
2000; Yokota & Mori, 2002). Id2, in particular, was shown to disrupt antiproliferative effects 
of tumour suppressor proteins of the Rb family, thus allowing cell cycle progression 
(Lasorella et al., 1996). Indeed, the pattern of the Id2 expression detected by Western 
blotting, confirmed the distribution of the phases of the cell proliferation detected by flow 
cytometry. This observation was previously published by our group suggesting a redox 
regulation of this protein (Borras et al., 2004). In addition, the studies of liver regeneration, 
process that involves DNA synthesis and cell proliferation, gave further support to our 
findings.  
It was demonstrated that when the increase of GSH after partial hepatectomy was 
prevented, the liver regeneration was delayed and the total liver amount of the DNA was 
lower than in the control group (Huang et al., 2001). Furthermore, an early increase in Id2 
gene has been demonstrated as well as the contribution of Id2 in the control of hepatocyte 
priming through modulation of c-myc expression (Rodriguez et al., 2006). All these support 
our notion that Id2 could be an excellent candidate as a protein marker of the redox 
regulation of cell proliferation in our models.   
3.2.2 PCNA as a possible redox sensor in the onset of DNA synthesis 
PCNA, a proliferating cell nuclear antigen, is a central protein in both DNA replication and 
repair. It’s a “sliding clamp” that localizes proteins, such as DNA polymerase, to DNA and 
thus enables the correct DNA replication.  
Replication of mammalian genome starts at thousands of origins, called replication foci, 
which contain PCNA and are activated at different times during S phase. The dynamics of 
replication foci is still a matter of debate; there are contradictory reports on the organization 
of the DNA replication sites in diverse cell types attributable to the differences in the 
technical approach (Dimitrova & Gilbert, 2000; Kennedy et al., 2000). According to 
Dimitrova, SD and Berezney, R (Dimitrova & Berezney, 2002) there is no fundamental 
difference in the spatiotemporal organization of the DNA replication in primary, 
immortalized and malignant mammalian cells. On the contrary, Kennedy’s group (Kennedy 
et al, 2000), observed different patterns of replication foci in primary versus immortalized 
cell lines, as well as their perinuclear localization in the contact-inhibited cells prior to cell 
cycle exit (Barbie et al., 2004). Another fundamental question was weather the replication 
foci are moving along the DNA in the process of the replication, or the DNA is spooling 
through fixed replication factories. It seems that the important body of evidence is 
accumulating supporting the fixed-replication-site model (Dimitrova & Gilbert, 2000; 
Leonhard et al., 2000). The replication machinary bind to DNA, but they are also tethered to 
an underlying framework called nuclear matrix or skeleton (Leonhardt et al., 2000). 
Regardless of the discrepancies in their findings, all the authors call attention to the 
importance of the preserving nuclear architecture in order to guarantee the correct 
development of the process of DNA replication (Dimitrova & Gilbert, 2000; Barbie et al., 
2004; Leonhardt et al., 2000). In addition, it has been shown that chromosome territory 
organization depends on association with the nuclear skeleton (Leonhardt et al., 2000). More 
than 20 years ago, Dijkwell et al. (Dijkwell & Wenink, 1986) postulated that the maintenance 
of the nuclear matrix, especially nuclear lamina, by preserving disulphide bonds depended 
on the level of nuclear thiols. In accordance to this work, Oleinick et al. (Oleinik et al., 1987) 
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reported that DNA-protein cross links, present at basal level as normal associations of 
chromosomal loops with the nuclear matrix proteins, can be increased by ionising radiation 
and removal of intracellular glutathione, and decreased by hydroxyl radical scavengers. The 
importance of the GSH in cell proliferation could be extrapolated to the safeguarding of the 
nuclear architecture, providing in that way a proper milieu for the DNA replication. Our 
results could provide support to the hypothesis of Bellomo et al (Bellomo et al., 1997) that 
reduced nuclear glutathione may modulate the structural organization of chromatin. It is 
tempting to speculate that the high nuclear GSH level we observed before (late G1 phase) 
and at the onset of cell proliferation (S phase) could provide the redox environment that 
stimulates chromatin decompaction by reducing disulfide bonds.  
3.3 Nuclear compartmentalization of glutathione as an important feature of 
proliferating cell: reduce to replicate 
The functional compartmentalization is an obvious characteristic of eukaryotic cell. The 
organelles, visible by light microscopy, are surrounded by membranes, which, although 
permitting communication, provide unique and defined environment in each one, which 
guarantee its accurate function. Probably the most remarkable examples of 
compartmentalization are oxidative phosphorylation in mitochondria, protein folding in 
endoplasmic reticulum and, for the purpose of this study the most interesting of all, DNA 
synthesis. It is interesting to note that, when the first two organelles are concerned, the 
dependence of their function on the correct GSH level has been thoroughly studied. The 
high intramitochondrial concentration of GSH is maintained by an active multicomponent 
transport system “pumping” glutathione from the cytosol into the matrix (Matensson et al., 
1990). On the contrary, for the correct folding of proteins into a native structure by disulfide 
bond formation, the GSH level and the ratio GSH/GSSG in the endoplasmic reticulum is 
maintained at extremely low level by the limited permeability of the vesicle membrane to 
GSH (Hwang et al., 1992). However, in the case of nuclear compartmentalization of 
glutathione the reports were scarce and contradictory over the years. This could be 
attributed to two main factors: methodological difficulties in measuring nuclear glutathione 
content and the focus of the research generally limited to confluent cells.  
3.4 Modifications of nuclear proteins along the cell cycle  
Various studies have demonstrated that the nucleus is more reduced than the cytosol 
(15mM GSH vs. 11 mM, respectively) (Bellomo et al., 1997; Schafer & Buettner, 2001; Soboll 
et al., 1995). An important number of nuclear proteins, including transcription factors, 
require a reduced environment to bind to DNA. More than 62 proteins are involved directly 
in transcription, nucleotide metabolism, (de)phosphorylation, or (de)ubiquitinylation, which 
are all essential processes for cell cycle progression (Connour et al., 2004). For instance, it 
appears that, at the onset of cell proliferation in the early G1 phase, an increase of ROS in the 
cytoplasm is necessary for the initiation of the phosphorylation cascade mediated by 
epidermal growth factor (EGF) that, subsequently, activates DNA replication and the cell 
division (Carpentes & Cohen, 1990). According to Jang and Surh (Jang & Surh, 2003) nuclear 
GSH may act as a transcriptional regulator of NF- B, AP-1, and p53 by altering their nuclear 
redox state. The transcription factor NF-κB is an example of distinct redox-sensitive 
activation and DNA binding (Hansen et al., 2006); it is activated by various physiological 
stimuli known to produce ROS; on the contrary, to permit DNA binding, similar to Fos, Jun, 
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and Nrf2, cysteine residue within DNA binding domain must be reduced. Both processes 
are guaranteed by the adequate redox state of the cytosolic and nuclear environment, 
respectively. 
Interestingly, the nuclear proteins underwent stronger glutathionylation before and at the 
onset of cell proliferation than at quiescence. It is not surprising if we bear in mind that high 
level of GSH in the nucleus could provide protection to the proteins against the oxidative 
threat coming from the cytoplasm at the early phase of cell proliferation, and that 
glutathiolation, as it is a reversible modification, could be just the way. On the other hand, 
based on the simplicity of the redox transition from thiol to disulfide and on the fact that the 
reversibility was energetically favourable, Cotgrave IA and Gerdes RG (Cortgreave & 
Gerdes, 1998) more than 10 years ago have proposed glutathionylation as a 
posttranscriptional modification with the regulative finality. They state that it offers “a 
strong possibility for transducing “oxidative information” from intracellular oxidants via 
the GSH redox buffer to individual proteins containing “regulatory thiols”. Also, recently, 
this posttranslational modification was proposed as a likely molecular mechanism for redox 
dependent signalling mediated by GSH (Fratelli et al., 2005). Thus, high level of GSH in the 
nucleus, observed before and at the onset of cell proliferation, could provide the “GSH 
redox buffer” necessary for the progressing of oxidant stimulated mitogenesis. It is 
encouraging to see that the findings of the present study have provided some support to the 
assumption that a dynamic intracellular redox environment directs the cell proliferation 
through redox sensitive cell cycle proteins. 
4. The depletion of nuclear glutathione hampers the cell cycle progression 
With the intention of providing further evidence of the importance of nuclear GSH in the 
initiation of cell proliferation, we have found ourselves in front of a challenge of depleting 
nuclear glutathione. A number of reports have focused on the consequences of the depletion 
of cellular glutathione levels on changes in cellular proliferation (Thomas et al., 1995; 
Hansen et al., 2006). However, all those reports were performed measuring cellular or total 
glutathione levels, but there is no information relating cellular proliferation with nuclear 
glutathione levels. A number of studies have indicated the existence of a nuclear GSH pool 
that resists depletion after exposure of cells to BSO (Thomas et al., 1995). BSO treatment 
resulted in the concentration dependent depletion of cytoplasmic GSH, while the depletion 
of mitochondrial and nuclear pool of GSH required concentrations higher than 100 µM, 
which induced DNA damage (Green et al., 2006). Spyrou and Holmgren (Spyrou & 
Holmgren, 1996) showed that inhibition of glutathione synthesis by 0.1 mM BSO was able to 
decrease GSH synthesis after treatment for 12 hours, but GSH-depleted cells grew as well as 
control 3T6 cells with no decrease in DNA synthesis. Thus, incubation of cells with low 
concentration of BSO, although decreases glutathione levels, does not change cell 
proliferation. On the other hand, Thomas et al. (Thomas et al., 1995) showed that non toxic 
concentrations of N-ethyl maleimide or DEM decreased the GSH level in the nucleus and 
cytoplasm to a similar extent, whereas the nuclear pool of GSH was much more resistant to 
BSO depletion.  
Based on this findings, we have designed a model to study the effects on the cell 
proliferation parameters caused by GSH depletion both in the nucleus and the cytoplasm, 
using 100µM DEM, comparing to the administration of 10 µM BSO when nuclear GSH level 
is preserved.  
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Fig. 3. Changes in cell proliferation caused by GSH depletion. 
As reported previously by various authors (Britten et al., 1991; Green et al., 2006; Thomas et 
al., 1995) nuclear GSH pool was preserved. By contrast, depletion of glutathione levels by 
DEM induces a marked decrease in nuclear glutathione levels. 
 
 
Fig. 4. The depletion of GSH in the nucleus. 
The compartmentalization of glutathione depletion could explain the observed differences 
in the inhibition of cell proliferation. Indeed, our results show that inhibition of glutathione 
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levels by DEM strongly impairs cell proliferation. This difference could be due to the fact 
that DEM decreases both nuclear and cytosolic glutathione levels in opposition to BSO, 
which only decreases cytosolic glutathione. It is worth mentioning that the impairment of 
cell proliferation could not be attributed to the alkylating properties of DEM, since the 
simultaneous administration of GSHe completely prevented it, nor to the toxicity of the 
treatment because the cell death was not significantly augmented. 
In addition, we have observed the delay in the cell cycle progression caused by DEM, when 
both nuclear and cytoplasmic GSH was depleted, which is absent in the treatment with BSO 
when nuclear GSH pool was preserved. Interestingly, Esposito et al. (Esposito et al., 2002) 
showed that direct administration of DEM on the nuclear extracts of COS7 cells induces cell 
cycle arrest. So, it is daring to speculate that, despite the depletion of cytoplasmic GSH with 
DEM could not be overlooked, the effect on the cell cycle progression could be attributed to 
the depletion of the nuclear GSH. Moreover, as Esposito shows, the depletion of nuclear 
GSH strongly induces a p53-independent accumulation of p21, which causes a cell cycle 
arrest. In our study, the expression of cell cycle regulatory protein, suggested previously to 
be under redox control, Id2, was decreased when the level of nuclear GSH was depleted.  
 
 
Fig. 5. Nuclear GSH depletion affects Id2 expression. 
It has been known that cell proliferation is regulated by a variety of mechanisms working to 
allow the activation and repression of growth stimulatory genes, one of them being the 
transcription factors. Previous in vitro reports show that the activity of transcription factors 
is related to its redox environment. In addition, change in the redox potential could induce 
variations in the activity of those transcription factors. Alterations as small as + 15 mV in the 
redox potential can result in transcription factor translocation and activation or deactivation, 
depending on the direction of the redox shift (Hutter et al., 1997; Sen & Packer, 1996; Sun & 
Oberley, 1996). Recently Reddy et al. (Reddy et al., 2008) have shown that Nrf2 deficiency 
leads to oxidative stress and DNA lesions, accompanied by impairment of cell-cycle 
progression, mainly G(2)/M-phase arrest. Both N-acetylcysteine and glutathione (GSH) 
supplementation ablated the DNA lesions and DNA damage-response pathways in Nrf2  
(-/-) cells; however only GSH could rescue the impaired co-localization of mitosis-
promoting factors and the growth arrest. Our results demonstrate for the first time that it is 
www.intechopen.com
 
Selected Topics in DNA Repair 
 
284 
nuclear GSH levels, and not total cellular glutathione levels, that specifically correlate with 
cellular proliferation. Glutathione is considered essential for survival in mammary cells and 
other eukaryotic cells, but not prokaryotic cells. However, although a number of important 
functions have been attributed to GSH, its outstanding role in nucleated, but not in 
prokaryotic cells, remains unknown. Our results underscore the important role of nuclear 
glutathione in cell physiology and suggest that manipulation of nuclear GSH levels could be 
of paramount importance during development and cancer. 
5. The occurrence of the glutathione in the nucleus; active transport, de novo 
synthesis, diffusion or something else 
How GSH enters the nucleus and how it is regulated during the different phases of the cell 
cycle is still a matter of debate. The regulation of such interactions is also unclear. According 
to Smith and colleagues (Smith et al., 1996), the possible biochemical mechanisms 
responsible for the turnover of nuclear GSH are the following: 1.GSH may be taken up from 
the cytoplasm into the nuclei either passively or through energy-dependent processes 
2.GSH may be synthesized de novo in the nucleus by the enzymes glutamate cysteine ligase 
and GSH synthetase 3.GSH may function to transport -glu-cys-cys.  
5.1 ATP dependent sequestration of the GSH to the nucleus 
The role of ATP-dependent mechanisms in maintaining the nuclear/cytoplasmic GSH 
concentration in hepatocytes was demonstrated by Bellomo and co-workers (Bellomo et al., 
1997). After 20 min of incubation with the uncoupler protonophore carbonyl cyanide m-
chlorophenylhydrazone (CCCP) the nuclear/cytoplasmic GSH gradient disappeared, but 
the total GSH content remain unchanged. This study was questioned by Briviba et al 
(Briviba et al., 1993) because of the use of monochlorobimane (BmCl). Despite its high 
specificity for glutathione this fluorochrome was found to be of no value in the study of 
cellular GSH distribution; once GSH-BmCl conjugate is formed it demonstrates an increased 
tendency of nuclear compartmentalization. Indeed, in our study using CMFDA, we have not 
found an ATP-dependent mechanism of nuclear GSH compartmentalization in 3T3 
fibroblasts. Ho and Guenthner, 1997 using nuclear fractions concluded that GSH is taken up 
by the nucleus by passive diffusion and no evidence for an ATP-dependent mechanism for 
GSH concentration was observed.  
5.2 Nuclear synthesis of glutathione  
Glutamate cysteine ligase (GCL) and GSH synthetase activities have been reported in nuclei, 
and a portion of 4-8% of cell GSH synthetic activity is considered capable of maintaining 
nuclear GSH levels (Ho and Guenthner, 1997). However, we could not find GCL expression 
in nuclei of 3T3 fibroblasts. In addition as previously reported BSO, a specific inhibitor of 
GCL was unable of decreasing nuclear glutathione levels. Thus, at least under our 
experimental conditions, the possible “de novo” synthesis of nuclear glutathione seems 
improbable in 3T3 fibroblasts. 
5.3 GSH enters nucleus via nuclear pores 
The nuclear pore complex is the biochemical machinery that controls the molecular traffic 
across the nuclear envelope (Feldherr & Akin, 1990; Nigg, 1997). Ions and small hydrophilic 
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molecules, like glutathione, are considered to move by free and fast diffusion across the 
nuclear pore (Ribbeck & Gorlich, 2001); nevertheless ion gradients and transnuclear ATP-
dependent membrane potential have also been reported (Nigg, 1997). In a series of creative 
experiments published in early 1990ies, Feldherr CM and Akin D (Feldherr & Akin, 1990; 
Feldherr & Akin, 1993), shown that permeability of nuclear envelope and nuclear transport 
were higher in proliferating than in quiescent cells. Reported seven fold reduce in the 
nuclear transport capacity was induced by the alterations in the characteristics of the pores 
and not by the changes within the cytoplasm, specifically, the decrease in ATP 
concentration. One pore forming protein that has been brought into the connection to 
nuclear glutathione content is Bcl-2. Voehringer and colleagues (Voehringer et al., 1998) 
showed that over-expression of Bcl-2 recruits GSH to the nucleus. The presence of this 
protein at the nuclear envelope was demonstrated (Krajewski et al., 1993) and the 
association with the nuclear pore complexes was suggested. Moreover, Zimmermann et al. 
(Zimmermann et al., 2007) demonstrated that GSH binds to Bcl-2 in mitochondria, 
providing a molecular basis for its antioxidant function.  
A clear picture emerges showing that the presence of a reduced nuclear environment, 
probably provided by glutathione, glutaredoxin and thioredoxin mainly, is of paramount 
importance in the physiology of cell cycle, underscoring the role of oxidative stress in cell 
proliferation. 
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